A detailed history of Avalon Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Avalon Trust CO holds 1,500 shares of EW stock, worth $112,215. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,500
Previous 2,050 26.83%
Holding current value
$112,215
Previous $189 Million 47.73%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $32,835 - $51,579
-550 Reduced 26.83%
1,500 $99 Million
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $52,687 - $58,943
-625 Reduced 23.36%
2,050 $189 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $1,039 - $1,400
-15 Reduced 0.56%
2,675 $185 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $199,759 - $227,331
2,690 New
2,690 $223 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Avalon Trust CO Portfolio

Follow Avalon Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Trust CO with notifications on news.